Hollencrest Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.8K Hold
2,500
﹤0.01% 574
2026
Q1
$48.1K Hold
2,500
﹤0.01% 558
2025
Q4
$47.4K Hold
2,500
﹤0.01% 577
2025
Q3
$46.6K Hold
2,500
﹤0.01% 567
2025
Q2
$46.1K Hold
2,500
﹤0.01% 530
2025
Q1
$43.7K Hold
2,500
﹤0.01% 544
2024
Q4
$43.3K Hold
2,500
﹤0.01% 561
2024
Q3
$46.5K Hold
2,500
﹤0.01% 525
2024
Q2
$38.5K Hold
2,500
﹤0.01% 559
2024
Q1
$36.9K Hold
2,500
﹤0.01% 532
2023
Q4
$35.7K Hold
2,500
﹤0.01% 538
2023
Q3
$34.9K Hold
2,500
﹤0.01% 528
2023
Q2
$29.4K Hold
2,500
﹤0.01% 574
2023
Q1
$28.8K Hold
2,500
﹤0.01% 567
2022
Q4
$31.1K Buy
+2,500
New +$31.9K ﹤0.01% 536

Other funds holding SBRA

Hollencrest Capital Management's SBRA Position: Q2 2026 in Review

Hollencrest Capital Management held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 2,500 shares worth $48.8K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Hollencrest Capital Management first reported a position in SBRA in Q4 2022 and has held it in 15 quarters since. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Hollencrest Capital Management held 2,500 shares of Sabra Healthcare REIT worth $48.8K as of Q2 2026.
  • Hollencrest Capital Management left its Sabra Healthcare REIT share count unchanged in Q2 2026.
  • Sabra Healthcare REIT made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #574 holding.
  • Hollencrest Capital Management first reported a position in Sabra Healthcare REIT in Q4 2022 and has held it in 15 quarters since.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.